Skandinaviska Enskilda Banken AB (publ) - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 132 filers reported holding SANA BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is 8.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2024$3,185,850
-45.4%
583,4890.0%0.02%
-48.3%
Q1 2024$5,834,890
+527.2%
583,489
+155.9%
0.03%
+480.0%
Q4 2023$930,240
+76463.0%
228,000
-27.4%
0.01%
-37.5%
Q3 2023$1,215313,9000.01%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
Trustees of Columbia University in the City of New York 281,250$6,334,0009.69%
Flagship Pioneering Inc. 34,239,018$771,063,0008.08%
Crestline Management, LP 3,210,937$72,310,0006.80%
SB Management Ltd 2,209,004$49,747,0005.10%
Omega Fund Management, LLC 843,750$19,001,0002.13%
HARVARD MANAGEMENT CO INC 1,163,601$26,204,0001.54%
Alphabet Inc. 2,812,500$63,338,0001.50%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 387,508$8,727,0001.03%
PUBLIC SECTOR PENSION INVESTMENT BOARD 4,131,249$93,036,0000.53%
Dragoneer Investment Group 1,500,000$33,780,0000.44%
View complete list of SANA BIOTECHNOLOGY INC shareholders